Chemed Corporation (CHE) News
Follow Chemed Corporation (CHE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 26 public stories across 12 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Chemed Reports Third-Quarter 2026 Revenue of $690.9 Million, EPS of $5.45
Revenue rose 10.6% year over year to $690.9 million, net income increased 11.5% to $71.6 million, and diluted EPS advanced 22.2% to $5.45. VITAS and Roto-Rooter growth contributed to the results.
EQUITY | Oct 29, 2026, 01:11 PM UTC
M
Labcorp and Chemed shares surge after third-quarter earnings
Labcorp shares were up around 10.4% and Chemed shares gained 9% on Wednesday, reaching over 52-week highs, according to the report. It attributes the moves to stronger-than-expected third-quarter earnings and bullish Wal
EQUITY | Oct 28, 2026, 05:57 PM UTC
M
Chemed Beats Q3 Expectations, Raises Guidance
Chemed beat Q3 expectations and raised guidance, with BofA citing strength at Vitas.
EARNINGS | Oct 28, 2026, 03:32 PM UTC
M
CHE Reports Fiscal Q3 Profit Up 9.11%
CHE reported fiscal third-quarter profit attributable to shareholders up 9.11% year over year, with basic EPS also reported.
EQUITY | Oct 28, 2026, 05:13 AM UTC
M
Chemed Reports Q3 2026 Results, Updates EPS Outlook
Chemed reported revenue of $690.9 million and adjusted EPS of $6.75 for the quarter ended September 30, 2026. Roto-Rooter revenue rose 7.5% to $233.5 million year over year. The company now expects 2026 adjusted EPS at o
EQUITY | Oct 27, 2026, 10:03 PM UTC
M
Chemed Reports Higher Q3 Adjusted Earnings and Revenue
Chemed reported higher adjusted earnings and revenue for the third quarter.
EQUITY | Oct 27, 2026, 09:15 PM UTC
M
Chemed Expects 2026 Adjusted EPS at or Above Prior Range High-End
Chemed now expects 2026 adjusted EPS at or slightly above the high end of its prior $25-$25.75 guidance range. FactSet's estimate is $25.49.
EARNINGS | Oct 27, 2026, 08:56 PM UTC
M
Chemed Reports Third-Quarter 2026 Results
Chemed Corporation reported its third-quarter 2026 results.
EQUITY | Oct 27, 2026, 08:39 PM UTC
M
Chemed Reports Third-Quarter Adjusted EPS of $6.75
EARNINGS | Oct 27, 2026, 08:28 PM UTC
M
Chemed Reports Q3 Results, Expects 2026 Adjusted EPS at or Above Guidance High End
VITAS revenue rose 12.2% year over year to $457.4 million, while Roto-Rooter revenue increased 7.5% to $233.5 million. Chemed expects full-year 2026 adjusted EPS at or slightly above the high end of prior guidance.
EQUITY | Oct 27, 2026, 08:18 PM UTC
M
Chemed Reports Third-Quarter Net Income of $71.6 Million
EARNINGS | Oct 27, 2026, 08:15 PM UTC
M
Chemed to report third-quarter 2026 earnings Oct. 27
Chemed said it will report third-quarter 2026 earnings on Oct. 27 and hold a conference call on Oct. 28.
EQUITY | Oct 01, 2026, 01:00 PM UTC
L
Chemed Initiated at Buy by UBS
Ratings actions from Benzinga
NEWS | Sep 25, 2026, 04:09 PM UTC
M
Chemed subsidiary acquires largest independent Roto-Rooter territory
Roto-Rooter Services Company, a wholly owned subsidiary of Chemed, said it acquired the largest independent Roto-Rooter franchise serving about 11 million people for $60.6 million.
EQUITY | Sep 16, 2026, 08:33 PM UTC
L
CHE - Roto-Rooter Buys Largest Franchisee Territory
CHE - Roto-Rooter Buys Largest Franchisee Territory
NEWS | Sep 16, 2026, 08:30 PM UTC
H
CHE: VITAS outperforms with margin gains and Florida growth as Roto-Rooter stabilizes amid higher costs
Second quarter results exceeded expectations, prompting increased guidance. VITAS continues to outperform, driven by margin expansion and Florida growth, while Roto-Rooter has stabilized despite higher marketing costs. D
EARNINGS | Sep 15, 2026, 04:44 PM UTC
L
Chemed to present at Jefferies 2026 Healthcare Services conference Sept. 15
Chemed Corporation said it will deliver a presentation at the Jefferies 2026 Healthcare Services and Technology Conference on Tuesday, September 15, 2026 at about 10:55 a.m. CT in Nashville.
EQUITY | Sep 08, 2026, 01:08 PM UTC
L
Chemed to present at Jefferies 2026 Healthcare Services Conference
Chemed Corporation said it will present at the Jefferies 2026 Healthcare Services Conference.
EQUITY | Sep 08, 2026, 01:00 PM UTC
M
Chemed unit Vitas faces federal investigation call
Capitol Forum reports an expert reviewed internal documents tied to Vitas admitting patients to hospice after misdiagnosed dementia and fudged evaluation scores.
EQUITY | Aug 27, 2026, 05:06 PM UTC
L
Chemed Corporation Declares 70 Cent Dividend
Chemed Corporation declares quarterly dividend
EQUITY | Aug 06, 2026, 03:57 PM UTC
H
CHE Beats Q2 Estimates
CHE beats Q2 estimates
EQUITY | Jul 29, 2026, 12:53 PM UTC
L
Chemed raises FY adjusted EPS view to $25-$25.75 from $24-$24.75
Consensus is $24.34. The...
EARNINGS | Jul 28, 2026, 08:24 PM UTC
L
Chemed reports Q2 adjusted EPS $6.06, consensus $5.60
Reports Q2 revenue...
EARNINGS | Jul 28, 2026, 08:24 PM UTC
L
CHE Chemed RESULTS: Q2, Q2 Net Income $67.703M, Q2 EPS $5.13, Q2 REV $673.3M vs. EST $665M, Q2 ADJ EPS $6.06 vs. EST $5.6
CHE Chemed RESULTS: Q2, Q2 Net Income $67.703M, Q2 EPS $5.13, Q2 REV $673.3M vs. EST $665M, Q2 ADJ EPS $6.06 vs. EST $5.6
EARNINGS | Jul 28, 2026, 08:17 PM UTC
L
Chemed Raises FY2026 Adj EPS Guidance from $24.00-$24.75 to $25.00-$25.75 vs $24.34 Est
Chemed (NYSE: CHE ) raises FY2026 Adj EPS guidance from $24.00-$24.75 to $25.00-$25.75 vs $24.34 analyst estimate..
EARNINGS | Jul 28, 2026, 08:16 PM UTC
H
earnings calendar: • earnings before the open: ab abg alks amt awi axta ba cac carr cbu CMS cnc cts curb cvlt dino dte ecl fele fmx glw GSK
earnings calendar: • earnings before the open: ab abg alks amt awi axta ba cac carr cbu CMS cnc cts curb cvlt dino dte ecl fele fmx glw GSK hlt hri hubb iny inio iqv itri itw ivz jblu ko naut osk pcar phg pii pny pypl rc
EQUITY | Jul 28, 2026, 10:47 AM UTC